The Patent Finder

Enhanced Delivery Epinephrine Compositions

Aquestive Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,191,737Enhanced Delivery Epinephrine Compositions
In force
 · High confidence
UsedRemaining
Aquestive Therapeutics, Inc.In forceHigh confidence
US 12,023,309Enhanced Delivery Epinephrine Compositions
Term ended
Term ended Apr 26, 2021 · High confidence
Aquestive Therapeutics, Inc.Term endedTerm ended Apr 26, 2021High confidence
US 12,427,121Enhanced Delivery Epinephrine Compositions
Term ended
Term ended Apr 26, 2021 · High confidence
Aquestive Therapeutics, Inc.Term endedTerm ended Apr 26, 2021High confidence
US 12,433,850Enhanced Delivery Epinephrine and Prodrug Compositions
Term ended
Term ended Apr 26, 2021 · High confidence
Aquestive Therapeutics, Inc.Term endedTerm ended Apr 26, 2021High confidence
Application 15/717,859Enhanced Delivery Epinephrine Compositions
Abandoned
Abandoned Mar 2, 2018
Aquestive Therapeutics, Inc.AbandonedAbandoned Mar 2, 2018
Application 17/514,805Enhanced Delivery Epinephrine Compositions
Abandoned
Abandoned Jun 10, 2022
Aquestive Therapeutics, Inc.AbandonedAbandoned Jun 10, 2022
Application 17/549,219Enhanced Delivery Epinephrine and Prodrug Compositions
Pending
Not granted
Aquestive Therapeutics, Inc.PendingNot granted
Application 18/413,556Enhanced Delivery Epinephrine and Prodrug Compositions
Pending
Not granted
Aquestive Therapeutics, Inc.PendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Aquestive Therapeutics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited